Berberine

One of the most researched plant compounds for glucose, lipids, and cancer biology.

What it is

Berberine is an alkaloid found in goldenseal, barberry, and other plants. It activates AMPK — the same cellular energy sensor activated by metformin — making it one of the most pharmacologically active compounds in the botanical world.

Why it matters

Berberine simultaneously lowers fasting blood glucose, reduces LDL cholesterol, and is being studied extensively in oncology for its ability to inhibit cancer cell proliferation, induce apoptosis, and reduce tumour inflammation. The AMPK activation pathway also improves insulin sensitivity, which is directly relevant to the Warburg effect cancer cells exploit.

The evidence

Multiple meta-analyses confirm berberine's glucose-lowering effect is comparable to metformin in type 2 diabetes. Pre-clinical evidence for anti-cancer effects is extensive across multiple tumour types. Dosing used in clinical trials: 500mg three times daily with meals.

This information is for educational purposes and does not constitute medical advice. Always discuss supplement use with your care team, particularly if you are undergoing active cancer treatment.

Dosing

500mg 2–3× per day with meals. Berberine has a short half-life — consistent timing matters. Effects on glucose are measurable within days; full lipid-lowering effects appear over 3 months.

Cautions

Can lower blood glucose significantly — monitor if on diabetic medications or during fasting protocols. Moderate drug interactions via CYP3A4. May cause GI discomfort initially — start with one dose daily and titrate up. Not recommended in pregnancy.